Clinical Trials on Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1 in Korea, Democratic People's Republic of
Total 223 results
-
Samsung Medical CenterCompletedLocally Advanced or Metastatic Non-clear Cell Type Renal Cell CarcinomaKorea, Republic of
-
Seoul National University HospitalSeoul National University Bundang Hospital; SMG-SNU Boramae Medical CenterActive, not recruitingLocally Advanced or Metastatic NSCLCKorea, Republic of
-
Seoul National University HospitalAstraZeneca; Korean Cancer Study GroupCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of
-
Seoul National University HospitalTerminatedCarcinoma, Papillary, FollicularKorea, Republic of
-
Seoul National University HospitalClinical Research Center for Solid Tumor, KoreaCompletedLocally Advanced Head and Neck Squamous Cell CarcinomaKorea, Republic of
-
Asan Medical CenterSamsung Medical Center; Seoul National University Hospital; Kyungpook National...UnknownMetastatic Renal Cell CarcinomaKorea, Republic of
-
Asan Medical CenterCompletedMetastatic Renal Cell CarcinomaKorea, Republic of
-
PfizerCompletedAdvanced Renal Cell CarcinomaKorea, Republic of
-
AstraZenecaCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of, China, Japan
-
Seoul National University HospitalTerminatedMetastatic Malignant Melanoma and Renal Cell CarcinomaKorea, Republic of
-
Korean Association of Endocrine SurgeonsCompletedPapillary Thyroid MicrocarcinomaKorea, Republic of
-
CHA UniversityRecruitingLocally Advanced CholangiocarcinomaKorea, Republic of
-
Yonsei UniversityRecruitingKidney Cancer | Synchronous Neoplasm | Clear Cell Renal Cell Carcinoma MetastaticKorea, Republic of
-
PfizerRecruitingLocally Advanced or Metastatic ER+ HER2- Breast Cancer | Locally Advanced or Metastatic Castration-resistant Prostate Cancer | Locally Advanced or Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Korea, Republic of, Japan
-
Seoul National University HospitalActive, not recruitingThyroid Cancer | Papillary Thyroid MicrocarcinomaKorea, Republic of
-
Korean Urological Oncology SocietyPfizerUnknownClear Cell Renal Cell Carcinoma | MetastasisKorea, Republic of
-
Seoul National University HospitalRecruitingThyroid Cancer | Papillary Thyroid MicrocarcinomaKorea, Republic of
-
Yonsei UniversityUnknownRecurrent or Metastatic Squamous Cell Carcinoma of Head and NeckKorea, Republic of
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR T790M+ NSCLCCanada, Korea, Republic of, Taiwan
-
National Cancer Centre, SingaporeHoffmann-La Roche; Sirtex Medical; Singapore Clinical Research InstituteRecruitingLocally Advanced Hepatocellular CarcinomaKorea, Republic of, Singapore
-
Eisai Korea Inc.CompletedLocally Advanced or Metastatic Breast CancerKorea, Republic of
-
Seoul National University HospitalUnknownLocalized Renal Cell CarcinomaKorea, Republic of
-
Vaxcell Bio, Co., Ltd.CompletedLocally Advanced Hepatocellular CarcinomaKorea, Republic of
-
BeyondBio Inc.UnknownLocally Advanced or Metastatic Pancreatic CancerKorea, Republic of
-
Asan Medical CenterIpsenNot yet recruitingRenal Cell CancerKorea, Republic of
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; Gilead Sciences; Nektar TherapeuticsRecruitingLocally Advanced or Metastatic Urothelial CarcinomaKorea, Republic of, United States, Taiwan, Australia, United Kingdom, France, Greece, Italy, Belgium, Spain, Canada, Denmark, Germany
-
Rainier TherapeuticsTerminatedUrinary Bladder Disease | Locally Advanced or Metastatic Urothelial Cell Carcinoma | Urological DiseasesUnited States, Spain, Belgium, France, Germany, Italy, Korea, Republic of, Turkey, Hungary, Netherlands, Serbia, Poland, Russian Federation, Sweden, Moldova, Republic of, Denmark, Ukraine
-
Samsung Medical CenterCompletedAdvanced or Recurrent Esophageal Squamous Cell CarcinomaKorea, Republic of
-
Yonsei UniversityActive, not recruitingHistologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard TreatmentKorea, Republic of
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced orKorea, Republic of
-
Seoul National University HospitalPfizerCompletedRenal Cell Carcinoma | Nonclear Cell | Temsirolimus ResistanceKorea, Republic of
-
Yonsei UniversityRecruitingClear Renal Cell Cancer (< 7cm Size)Korea, Republic of
-
Asan Medical CenterUnknownAdvanced Urothelial CarcinomaKorea, Republic of
-
Yonsei UniversityUnknownInoperable or Recurrent or Metastatic Esophageal Squamous CarcinomaKorea, Republic of
-
Seoul National University HospitalCompleted
-
Bristol-Myers SquibbCompletedLocally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal JunctionFrance, Poland, Russian Federation, Taiwan, United States, Hong Kong, Spain, Germany, Italy, Japan, Korea, Republic of, Singapore
-
BayerCompletedCarcinoma, Renal Cell | Carcinoma, Renal Cell (Advanced)Poland, China, Slovakia, France, Germany, Indonesia, Korea, Republic of, Sweden, Philippines, Austria, Colombia, Czech Republic, Mexico, Russian Federation, Slovenia, Argentina, Greece, Netherlands
-
Samsung Medical CenterUnknownRenal Cell CarcinomaKorea, Republic of
-
Regeneron PharmaceuticalsSanofiCompletedRecurrent Squamous Cell Carcinoma of Head | Recurrent Squamous Cell Carcinoma of Neck | Metastatic Squamous Cell Carcinoma of Head | Metastatic Squamous Cell Carcinoma NeckKorea, Republic of, United Kingdom
-
Samsung Medical CenterUnknownFirst Line Chemotherapy | Capecitabine Plus Cisplatin Versus Capecitabine Plus Paclitaxel | Advanced or Recurrent Esophageal Squamous Cell CarcinomaKorea, Republic of
-
Seoul National University HospitalCompleted
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Korea, Republic of, China, Spain, Taiwan, Japan, Argentina, Canada, Croatia, Greece, Ireland, Malaysia, Netherlands, Portugal, Romania, Thailand, Turkey, United Kingdom
-
Yonsei UniversityNot yet recruitingLocally Advanced Nasopharyngeal CarcinomaKorea, Republic of
-
Sung Yong OhUnknownMetastatic Cancer | Esophagus Squamous Cell Carcinoma (SCC)Korea, Republic of
-
Rainier TherapeuticsTerminatedUrinary Bladder Disease | Locally Advanced or Metastatic Urothelial Cell Carcinoma | Urological DiseasesItaly, Spain, United States, Korea, Republic of, Turkey, Taiwan, Sweden, Czechia, United Kingdom
-
Yonsei UniversityCompletedRenal Cell CarcinomaKorea, Republic of
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
AstraZenecaTerminatedGastric Cancer | Advanced Solid Malignancies | Solid Tumour | Child-Pugh A to B7 Advanced Hepatocellular Carcinoma | EGFR and/or ROS Mutant NSCLC | Lung Metastasis CarcinomaKorea, Republic of
-
PfizerCompletedAdvanced Renal Cell CarcinomaKorea, Republic of, Japan, China
-
Samsung Medical CenterCompletedRenal Cell Carcinoma | Hepatocellular CarcinomaKorea, Republic of